Guaifenesin Syrup and Dextromethorphan Syrup Expectorant/Cough Suppressant

Manufacturer
Major Pharmaceuticals
Effective date
2025-01-29
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 00:54:44

Label at a glance#

ProductGuaifenesin and Dextromethorphan
Active ingredientGUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE
Label structure9 sections

Indications and uses

• helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive. • temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold.

Dosage and administration

Follow dosage below or use as directed by a physician.  do not take more than 6 doses in any 24-hour period.  single use cup. Dose only with cup provided.  each cup delivers 10 mL  mL = Milliliter Age (yr) Dose (mL) adults and children 12 years and over 10 mL every 4 hours children 6 years to under 12 years  5 mL every 4 hours  children under 6 years of age ask a doctor

Storage and handling

 Each 10 mL contains: sodium 8 mg.  Store at 20° to 25°C (68° to 77°F). Protect from light.

Label contents#

Full prescribing information#

Actve ingredient (in each 10 mL)                                                                                                                       Purpose

OTC - ACTIVE INGREDIENT SECTION

Guaifenesin 200mg ...................................................................................................................................... Expectorant
Dextromethorphan hydrobromide 20mg .......................................................................................................Cough Suppressant

Uses

INDICATIONS & USAGE SECTION

• helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive.
• temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold.

Warnings

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

• cough that occurs with too much phlegm (mucus)
• cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis or emphysema

Stop use and ask a doctor if

OTC - STOP USE SECTION

• cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache.  These could be signs of a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

Follow dosage below or use as directed by a physician.
 do not take more than 6 doses in any 24-hour period.
 single use cup. Dose only with cup provided.
 each cup delivers 10 mL
 mL = Milliliter

Age (yr) Dose (mL)
adults and children
12 years and over

10 mL every 4 hours

children 6 years to under 12 years 5 mL every 4 hours 
children under 6 years of ageask a doctor

Other information

STORAGE AND HANDLING SECTION

Each 10 mL contains: sodium 8 mg.
 Store at 20° to 25°C (68° to 77°F). Protect from light.

Inactive ingredients:

INACTIVE INGREDIENT SECTION

anhydrous citric acid, FD&C Red No. 40, flavor, glycerin, menthol, purified water, sodium benzoate, sodium citrate dihydrate, sodium saccharin, sucrose.

Questions or comments?

OTC - QUESTIONS SECTION

Call1-800-845-8210

How Supplied

HOW SUPPLIED SECTION

  • Guaifenesin and Dextromethorphan Syrup is a red, cherry flavored syrup and is available in the following dosage form:
    NDC 0904-7513-66: 10 mL unit dose cup, in a tray of ten cups

Professional Note: Guaifenesin has been shown to produce a color interference with certain clinical laboratory determinations of 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).

R10/24

Distributed by:

MAJOR® PHARMACEUTICALS
Indianapolis, IN  46268

PRINCIPAL DISPLAY PANEL -10 mL Unit Dose Cup

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Delivers 10 mL
NDC   0904-7513-66

GUAIFENESIN DEXTROMETHORPHAN

200 mg/20 mg per 10 mL

See Insert for Drug Facts
For Institutional Use Only

 

 

Lid- Guaifenesin & DM 200 mg/20mg-per 10 mL
Lid- Guaifenesin & DM 200 mg/20mg-per 10 mL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
996520dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral SolutionPSN3
996520dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral SolutionSCD3
996520dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 5 ML Oral SolutionSY3
996520dextromethorphan hydrobromide 15 MG / guaifenesin 150 MG per 7.5 ML Oral SolutionSY3
996520dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 10 ML Oral SolutionSY3

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DEXTROMETHORPHAN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
GUAIFENESIN Pharmacologic Class Indexing1Indexing - Pharmacologic Class20211129

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
bf324df6-7127-7deb-def5-2681c136cd03Product name320250325
43a1ed49-eae2-4840-8075-cb4b33478540Product name120230425
ba088a92-ab5e-b2d4-e908-f5ea691b7587Product name720210201
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
4fe95224-f543-4dbb-9445-8cca122b48c8Product name120150609
e8718272-64cb-4436-969b-176c3067c8f4Product name120150609
106ff02a-57e1-4c4c-a307-fd582ff4e311Product name120150212
76633df9-0d59-4b88-03ed-21dee1b966f8Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0904-7513-66Guaifenesin and Dextromethorphan10 mL in 1 CUP, UNIT-DOSESYRUP103
0904-7513-72Guaifenesin and Dextromethorphan10 in 1 CASESYRUP103
0904-7513-72Guaifenesin and Dextromethorphan10 in 1 TRAYSYRUP103

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0904-7513GUAIFENESIN AND DEXTROMETHORPHAN SYRUP [MAJOR PHARMACEUTICALS]3Current NDC, 3 package rows20250211_51e48201-bb62-4e89-85eb-e4a416f93522.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0904-7513-66ML - Milliliter0904-7513c5b195e2-8a37-404b-a8b6-a7d4be51d37f12025-03-04
0904-7513-72ML - Milliliter0904-75136d1a55ed-fd2b-4b50-8384-f7c7d1fd872a12025-03-04

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0904-75130904-7513-66, 0904-7513-72

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Guaifenesin and DextromethorphanGUAIFENESIN AND DEXTROMETHORPHANMajor Pharmaceuticals51e48201-bb62-4e89-85eb-e4a416f935222025-01-29WarningsExact identifier
ndc (package): 0904-7513-72
ndc (package): 0904-7513-66
ndc (product): 0904-7513
ndc11 (package): 00904751366
ndc11 (package): 00904751372
spl id: f4e2de93-edd9-4f0f-ab5c-305bf82ca380
spl set id: 51e48201-bb62-4e89-85eb-e4a416f93522

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.